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Foreword
Human resources for health are at a critical low. The World Health Organization estimates that the current shortage of health 
workers is in excess of 7.2 million worldwide and that, by 2035, the shortage will reach 12.9 million. Pharmacists, in particular, 
are lacking in the workforce in many countries. In addition, education and training needs to be strengthened globally.
Pharmacy needs a global vision that encompasses the sharing of experiences, gathering of evidence and collaborative guidance 
to facilitate country-level initiatives.
FIPEd is the name given to the component group of the International Pharmaceutical Federation (FIP) that is bringing together 
all of the federation’s efforts in transforming and strengthening professional pharmacy and pharmaceutical sciences education 
globally. It is organised as a cross-cutting initiative that includes both of the boards of FIP as well as its governance bodies.  
More than 100 practitioner and scientific educators and over 130 deans of schools of pharmacy from throughout the world are 
involved in congress programming on educational issues. 
The FIPEd team prepares technical and policy papers on key areas of education, contributes to an online international journal on 
pharmacy education, gathers leaders in education to establish a future agenda for transformation of pharmaceutical education,     
and links educational policy issues to national needs for workforce development, capacity building and quality assurance.
All of these initiatives are closely tied to enhancing appropriate medicines use in global health systems, with a strong emphasis 
on competency development across the continuum of the pharmaceutical workforce for practice and science. 
Workforce intelligence is one of the foundations for professional development in both pharmacy practice and pharmaceutical 
sciences, and the strengthening of workforce development in the global community of universities and training centres 
are integral parts of FIP’s Vision 2020. This report links to two other FIP reports published in 2015: ‘Advanced Practice and 
Specialisation in Pharmacy’ and ‘Interprofessional Education’. FIP stakeholders have identified these topics as being globally 
important and valuable for professional leadership bodies worldwide. The strengthening and expansion of pharmacists’ 
roles and scopes of practice to assure responsible use of medicines is strongly reliant on a capable workforce that is socially 
accountable and trained to meet international standards for quality. In that vein, FIPEd works in close collaboration with the 
World Health Organization (WHO) and the United Nations Agency for Education and Social Development (UNESCO), as well as 
with many leading universities and national organisations. 
This FIPEd Global Report on Workforce Trends is the first publication of its kind to provide a baseline on the current growing 
global trend, regarding capacity building and pharmacist numbers. We share this knowledge from our members to our members 
and beyond to trigger dialogue and action that will result in stronger evidence-based policies. We hope that this will stimulate 
collaborations/partnerships between all stakeholders, and will include professional organisations and universities taking up the 
important role of advocating transformation of professional development education at the national level.
This report, and others like them, are only possible due to the commitment and expertise provided by the principal authors and 
the personnel who have contributed to case studies and the provision of evidence and data. This report represents a significant 
commitment of time and effort, and on behalf of the FIPEd, I am sincerely grateful to the individuals, organisations and 
institutions who have made these significant contributions. Without their contribution and commitment, these influential and 
data-rich publications would not be possible.
William N. Charman, BPharm, PhD
FIP Education Initiative (FIPEd) Steering Committee Chair
Sir John Monash Distinguished Professor
Dean, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University
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The aspiration of many countries towards establishing 
universal health coverage will require an enhanced health 
workforce, including pharmacists that can meet the need 
for pharmaceutical expertise in the population it serves. 
It is important to monitor trends in the workforce over time.
The countries identified as having data for each of the time 
points 2006, 2009 and 2012 were present in all WHO regions, 
with Europe having the most countries with data available 
and South East Asia the fewest.  
All WHO regions have experienced an increase in the density 
of pharmacists (measured as number of pharmacists per 10,000 
population) over the period 2006–12. However, some countries 
indicate a reduction in the density of pharmacists.
African countries show large relative increases in acceleration 
of capacity building, but remain significantly behind in terms 
of absolute capacity per capita.
South East Asian and Middle Eastern countries also show large 
proportional changes in pharmacist workforce.
The global trend is an increase in workforce across all nations 
and regions, and this is a move in the right direction towards 
improved access to, and availability of, pharmaceutical 
expertise. However, there is still much to be done, with 
some regions and low-income countries still displaying 
a disproportionately low number of pharmacists on small 
overall capacity for delivering pharmacy services.
PART 1
KEY MESSAGES
William N. Charman, BPharm, PhD
FIP Education Initiative (FIPEd) Steering Committee Chair
Sir John Monash Distinguished Professor
Dean, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University
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The aspiration of many countries towards establishing 
universal health coverage will require a health workforce, 
including pharmacists, that can meet the needs for 
pharmaceutical expertise of the population it serves.  
The WHO has set three density thresholds for skilled 
healthcare workers — 22.8, 34.5 and 59.4 per 10,000 population 
— to highlight the variation in workforce availability in 
2013. These thresholds are not described as benchmarks (for 
example, for countries to measure each other’s workforce 
against) but are suggested to form the basis of discussion on 
what the workforce requirement should be 
in order to improve health outcomes. It is regrettable, however, 
that no threshold has yet been defined for pharmacists. 
However, there is no universal coverage of workforce 
intelligence — human resource information systems are 
still weak in many countries and the number of countries 
publishing regular and consistent official workforce data 
is low. Changes in the number of skilled health professionals 
indicate that most countries are attempting to increase 
workforce availability, and using density of skilled healthcare 
workers is a proxy measure of this. However, density may 
decrease because population growth is higher than the growth 
of the workforce or because of emigration of workforce. 
It is therefore important to assess trends in the pharmacist 
workforce against countries’ populations, disease burden and 
economic situation. This report seeks to address some of these 
issues for the pharmacist workforce.
A bibliography can be found in annex 3.
FIP’s Global Pharmacy Workforce Surveys conducted in 2006, 
2009 and 2012 analysed, monitored and reported on the status 
of the pharmacy workforce at country level. In 2012, the survey 
collected workforce data for 90 countries and territories 
representing 2.5 million pharmacists and nearly one and a half 
million technicians and support workers. Fifty-one countries 
responded to the 2009 report and 34 to the 2006 survey.
A key message from the 2006, 2009 and 2012 Global Pharmacy 
Workforce Reports was that pharmacy workforce density 
varied considerably between countries and WHO regions and 
generally correlated with population numbers and country 
level economic development indicators. Those countries and 
territories with lower economic indicators tended to have 
relatively fewer pharmacists and pharmacy technicians.
Access to high quality health services is vital for the delivery 
of a nation’s positive health outcomes. For example, the 
reduction of morbidity associated with long-term conditions 
requires access to pharmacy teams who can provide medicines 
and advice. Ensuring the availability of an appropriately 
skilled pharmacy workforce within services and facilities 
with effective distribution across a nation is an important 
approach for improving equitable access. Each country in 
this report started from a different baseline in terms of the 
number of pharmacists. The impact of changes in the density 
of the pharmacy workforce (whether this is an increase or 
decrease) on health outcomes is difficult to judge. Additionally, 
changing epidemiology and disease burden at a country level 
as well as population increases need to be considered and an 
assessment made as to whether the development of pharmacy 
human resources has adapted and made an impact over time.  
The proportion of women in the pharmacy workforce 
continues to increase resulting in more part-time working 
and therefore a greater headcount being required to meet 
demand. Productivity of pharmacists in many locations is 
being increased due to technology (use of robotics) and 
optimising skill mix (expansion of the pharmacy technician 
role). Conversely demand for pharmacists is also increasing 
in some areas because of the creation of new roles in order 
to mitigate shortages in other healthcare professions such 
as medicine and nursing.
PART 2
INTRODUCTION AND CRITICAL APPRAISAL OF NEW HUMAN 
RESOURCES FOR HEALTH (HRH) EVIDENCE SINCE 2012
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This section presents the data and analysis of the trends 
in the pharmacy workforce covering the time span of 2006, 
2009 and 2012. Trends will be identified (for data that were 
collated in 2006, 2009 and 2012) and comparisons made. 
The corresponding country population data for these years 
was extracted from the World Bank database, which uses 
a consistent methodology for capturing demographic 
and economic data. Pharmacy workforce data capture 
has previously been described in the FIPEd reports for the 
corresponding years (available from http://www.fip.org/
educationreports).
The methodology proceeded with the following steps:
       1.     Access FIP workforce data collated in 2006, 2009   
               and 2012. The data focused (due to limitations from  
               2006 databank) on pharmacist workforce capacity;
       2.    Identify country level data available across at least two  
              of the three time points (2006, 2009 and 2012);
       3.    For countries where there is a gap in one data point,  
              undertake a literature and data search to capture the  
              missing data;
       4.    Plot data over the three time points to identify trends.
Quality assurance was based on previous reporting and 
identification of data outliers for cross-checking. The accuracy 
of the dataset was checked with previous respondents when 
possible and independent checking was conducted before 
being prepared for analysis. 
Countries identified for the trends analysis are shown in table 
1 by WHO region.
Table 1: Countries identified for the trends analysis by WHO region.
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Table 1: Countries identified for the trends analysis by WHO region (cont.).
Matching data across the three time points (2006, 2009, 2012) 
and charting pharmacist capacity across these dates provides 
an overview as seen in figure 1 (capacity is measured as 
“density”: the number pharmacists per 10,000 population 
and serves as a standardised measure for the purposes of this 
report). Table 2 describes the mean percentage change 
in pharmacist density for each WHO region in this sample.
Table 2: Mean percentage change in pharmacist density per 10,000 
population by WHO region 2006–12.
TRENDS ANALYSIS
WHO Region                    
Africa  
                                
                                                         
              
               
                                            
                                         
Eastern                                   
Mediterranean
 
Europe  
Countries 3-digit codes
ETH              
GHA           
KEN
MLI           
NGA
TZA     
UGA
 ZWE 
EGY
ISR
JOR
PAK
SUD 
AUT
BEL
HRV
CZE
FIN
FRA
DEU
HUN
ISL
IRL
Countries        
Ethiopia                    
Ghana                      
Kenya
Mali   
Nigeria
Tanzania           
Uganda
Zimbabwe            
Egypt              
Israel                 
Jordan                
Pakistan
Sudan 
Austria
Belgium
Croatia
Czech Republic
Finland
France  
Germany
Hungary
Iceland
Ireland
WHO Region    
Europe  
Pan-America
South East Asia
Western Pacific
Countries 3-digit codes
ITA
MKD
MLT
NOR
PRT
ESP
CHE
TUR
GBR
 ARG
BRA
CAN
CRI
MEX 
URY
USA
CAM
IND
IDN
NPL
THA
AUS
JPN
KOR
TWN
SGP
VNM 
Countries        
Italy
Macedonia, Rep 
Malta
Norway
Portugal 
Spain
Switzerland
Turkey
UK
Argentina
Brazil
Canada
Costa Rica
Mexico 
Uruguay 
USA
Cambodia
India
Indonesia
Nepal
Thailand 
Australia
Japan
Republic of Korea
Singapore
Taiwan, China  
Vietnam 
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Figure 1: Changes in mean density 2006–12 (n=51).
Figure 1 and table 2 show proportional changes in pharmacist 
capacity over the three-time points. Figure 1 displays this as 
absolute changes, in other words as the absolute pharmacist 
density per capita, while table 2 shows this as relative  
per cent changes; it is important to remember, and this will be 
emphasised during the course of this report, that percentage 
changes and absolute changes may tell different stories. 
A small change in the absolute pharmacist density in a 
country with very low capacity to begin with can result in 
a large percentage increase; conversely a small percentage 
increase in a country with high-density will result in a large 
absolute figure for workforce headcount. Within the WHO 
regions there are also significantly wide variances that can 
make interpretation of aggregate statistics difficult. However 
it is clear from figure 1 that the global trend for pharmacist 
workforce is increasing, and based on these data presented 
here we estimate this increase to have been around 16% over 
the period concerned.
Figure 2 shows these median increases in density split by WHO 
region and presented as cumulative proportional changes over 
the period 2006–12.
Figure 2: Proportional change in absolute capacity by WHO region.
Again, converting changes to relative proportional changes 
may mask small absolute trends, particularly in smaller nations 
or nations with low capacity to begin with. Figure 2 does serve 
to indicate differing rates of increase (rate of change) across 
WHO regions in absolute terms, with Africa having the smallest 
absolute changes in capacity.
Annex I describes in detail how populations, World Bank 
Classification and pharmacist density has changed over the 
time points 2006, 2009 and 2012.
Global picture
Charting the change in workforce density over the period 
2006–12 provides a meaningful picture of workforce capacity 
trends. The full sample (n=51 countries) is shown in figure 3a; 
countries and territories are identified by the ISO three-letter 
abbreviation (see appendix 2 for alphabetic order) to maintain 
clarity. The cluster of countries at the bottom of figure 3a are 
those that have very low pharmacist densities, and due to 
scaling of the vertical axis cannot easily be identified on this 
chart; figure 3b shows this cluster in expanded scale detail for 
comparison.
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Figure 3a: Time trend for full data sample 2006–12.
201220092006
P
h
a
rm
a
ci
st
s 
p
er
 1
0,
00
0 
p
o
p
u
la
ti
o
n
25
20
15
10
5
 MLT
 MLT
 JPN
 JPN
 JOR; ISL
 JOR
 EGY
 EGY
 TWN
TWN
 ESP
 ESP
 ISL
 ITA; HUN; GBR
 ITA
 PRT; CAN
 PRT
 FRA; BEL; KOR  FRA; BEL; AUS
IRL
 AUS; CHE; FIN; USA
 IRL
 CAN
 MKD
 MKD; DEU
  DEU 
 CHE
 GBR; CRI
 CRI
HRV; BRA; IND
 CZE; AUT
 ISR; CZE
 ISR
 HRV; AUT
  FIN;HUN
 IND; NOR; MEX MEX
 KOR
 NOR  TUR
 TUR; URY
 THA
 THA
 SGP
 SGP
 SYR
 SYR
 URY
 ARG
 BRA
 USA
 ARG
0
CAM;ETH;GHA;IDN;
KEN;MLI;NPL;NGA;
PAK;SUD;TZA;UGA;
VNM;ZWE
For the these countries, 
see next figure:
10
.................................................................................. ..................................................................................
Figure 3b: Time trend for low capacity data cases (sub-set Fig 3a).
Figure 4: Relative capacity change as a Z-score.
A summative chart to show relative changes in capacity is 
provided in figure 4 (using a Z-score, or standard deviation unit 
for scaling purposes), and shows more clearly that, with the 
data provided, not all countries have been increasing capacity, 
although changes in overall population denominators may 
contribute to the negative increases. 
It also shows that some countries with small initial capacity 
(for example Sudan, Uganda) have proportionally increased 
capacity, relatively, to a significant extent, although once 
again their absolute capacity density remains very low in 
comparison with other, more high-income countries.
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Figure 5 through to figure 10 shows the trends in workforce 
from 2006–12 for the sample split by WHO region.
Figure 5: Time trend for Africa region data cases 2006–12.
Figure 6: Time trend for the region of the Americas data cases 2006–12.
Figure 7: Time trend for Eastern Mediterranean region data cases 2006–12.
Figure 8:Time trend for Europe region data cases 2006–12.
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The workforce density data was also examined by 
country-level income classification (World Bank) and  
presented as figures 11 and 12 for individual countries in the 
sample. Figure 13 shows the aggregated capacity change (as 
absolute density) across the time period using World Bank 
income level classification.
Figure 11: Time trend for low & lower middle income data cases 2006–12.
Figure 9: Time trend for Africa region data cases 2006–12.
Figure 10: Time trend for SE Asia region data cases 2006–12.
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Figure 12: Time trend for high & upper middle income data cases 2006–12.
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Figure 14: Dual plot of relative and absolute change to capacity 2006–12
(Z scores).
Figure 13: Capacity change (density) for World Bank classified countries.
 
 
 
 
 
Figure 13 shows that capacity change is more prevalent in 
higher-income countries and is associated with economic 
factors. Although some African nations, for example, have 
made significant relative increases in capacity development 
(Uganda and Sudan have increased their own capacity by high 
percentages) in relation to other countries, Africa remains 
capacity-poor overall.
Presenting data on workforce is always problematic, as has 
been alluded to earlier in this report.  Presenting proportional 
change (which is easy to visualize) or absolute change 
(harder to interpret but more realistic) is challenging. Figure 
14 illustrates this, as an attempt to present both relative 
and absolute aggregated workforce data. Change in relative 
capacity and change in absolute capacity are shown as 
converted Z-scores for the sample data; negative values on 
the vertical axis do not indicate a negative effect, or numbers 
below zero, but are an indication of a value less than the 
sample mean.  
Hence, we can see that African region countries (aggregated) 
have higher than average relative change, but below average 
absolute change. These countries collectively are increasing 
capacity, proportionally, very quickly, but remain well below 
average for actual density, expressed as pharmacist per 10,000 
population. In other words, the acceleration of pharmacist 
production is ongoing, but it remains well below the global 
average for actual numbers. Again, some of these aggregated 
statistics have outliers incorporated into them, making for a 
wide variance within groupings.
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The countries identified as having data for each of the time 
points 2006, 2009 and 2012 were present in all the WHO 
regions, with Europe having the most countries with data 
available and South East Asia the fewest.  All WHO regions 
have experienced an increase in the density of pharmacists 
per 10,000 population over the period 2006–12. Some decreases 
observed in density of pharmacists may be a result of net 
migration to other countries or other factors such as changes 
in national health policy.
Mapping pharmacists per capita with the World Bank 
classification gives an indication of the relationship of 
the workforce with economic indicators. Global Pharmacy 
Workforce Reports have shown a linear association with 
total pharmacist numbers and World Bank classification. In 
other words, the higher the level of a country’s income the 
greater the number of pharmacists.  Figure 13 illustrates that 
the capacity change over the period 2006–12 (i.e. the change 
in   the mean number of pharmacists per 10,000 population) 
showed the largest increase for the upper-middle income 
countries compared with all other country income groups. 
This may reflect a greater increase in the growth in the 
economies classified as upper-middle income compared with 
other country income groups. 
Funding of the pharmacy workforce will also have an effect on 
its national workforce density. Adequate funding is required 
for workforce expansion, sometimes through financial 
incentives such as higher wages for pharmacists where 
there is a shortage — though this is of course dependent 
on the strength of a country’s economy. The World Bank 
Classifications (WBC) have generally remained static over 
the period analysed, except for Croatia, Ghana, Hungary, 
India, Jordan, Nigeria and Pakistan, all of which increased 
their incomes over the period 2006–09. An increase in income 
did not necessarily result in an increase in the density of 
pharmacists, with only Croatia, Ghana Jordan and Nigeria 
achieving a greater density. Pakistan experienced an initial 
increase in its pharmacist workforce but this was followed by 
a small decrease.  
The WBC may not be a sensitive enough measure since 
it will not necessarily identify economic downturns and 
recession (leading to budget cuts and service reductions in the 
healthcare sector often resulting in redundancies and freezes 
on recruitment of staff) in individual countries. It is important 
to consider that the lead time for training a pharmacist is five 
years on average, so increases in the training of the number   
of pharmacists will take at least five years to be translated into  
a workforce increase.
PART 4   
Although the density of pharmacists has increased 
substantially in many lower-income countries such as Ethiopia, 
their baseline still remains low compared with those of higher 
income countries. For both lower-income countries and 
higher-income countries overall workforce numbers should be 
determined by strategic goals set by health 
policy-makers considering demand for health services. 
However, in reality reaching these goals may be challenging 
because of variations in the production of the workforce (e.g. 
numbers of schools of pharmacy and the lag time between 
educating and deploying staff) leaving lower-income countries 
with chronically low numbers in comparison with higher-
income countries. 
Other influences that contribute to the dynamics of the 
workforce are the flows of pharmacists into and out of 
countries (immigration and emigration), part-time/interrupted 
practice and the proportion of workers reaching retirement 
age — all of these impact on the number of pharmacists 
available to nations.  Achieving a higher density of pharmacists 
also depends, in part, on the capacity of strategic workforce 
planners in Ministries of Health and structural issues such 
as recruitment and distribution of workers (including direct 
investment in the production of the workforce).
When considering changes in the density of pharmacists per 
country over time it is useful to consider what the effect is on 
pharmacy workforce balance. When there is a national ‘gap’ 
between supply and demand for the pharmacy workforce then 
imbalances occur. Variations in pharmacist density should not 
necessarily be considered a workforce imbalance. Changes 
may also reflect differences in role as pharmacists may be 
contributing to a nation’s healthcare in non-patient facing 
roles in the pharmaceutical industry and pharmaceutical 
manufacturing units. 
Additionally, density of pharmacists does not describe the 
productivity or distribution (and therefore accessibility, as 
generally healthcare workers tend to be more concentrated in 
urban rather than rural areas) of the workforce.  For instance, 
as health demand increases the healthcare workforce needs 
to shift either by increasing its supply or by increases in its 
productivity. Absolute numbers of pharmacists do not reflect 
the issue of part-time workers, especially if their proportion 
has a greater increase relative to the growth in the number of 
pharmacists. Failure to respond to increased health demand 
results in workforce imbalances and risks non-achievement of 
positive health outcomes.
PHARMACY WORKFORCE 
INTELLIGENCE SYNOPSIS
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Another factor may have an effect on changes in pharmacist 
density. For some nations, changes may result from migration 
of the workforce to other countries. Some countries actively 
train health workers and export them (evidence of this needs 
to be established for the pharmacy workforce). There may 
also be unplanned migration of health workers and this is 
evidenced by the percentage of pharmacists employed in 
countries in which they did not qualify (this information 
is often available from a nation’s register of pharmacists). 
Changes to the following will also impact on a nation’s density 
of pharmacists:
• Education and training processes;
• Healthcare policy and systems;
• Human-resources for health policy and processes;
• Sociocultural environment.
It is also possible that changes in pharmacist density relate 
to a country’s response to changes in disease burden. The 
Disability-Adjusted Life Year (DALY) is a common method 
of assessing the disease burden of a region or country. It 
measures the number of years of life lost due to premature 
mortality and years of life lost due to time lived in states of 
less than full health. The WHO does not use this measure as 
frequently as recent Global Pharmacy Workforce Surveys; 
however, the WHO did plot change in the top 10 DALYS 
between 1990 and 2010 for each country as published in the 
‘Universal Truth’ report of 2014. 
In future, for the purposes of the FIPEd workforce trends 
report, density of pharmacist workforce will be modelled 
against total DALYs for a country as a way of assessing the 
impact of the pharmacy workforce on the disease burden. The 
challenge will be finding evidence of the total DALYs for all 
countries over a period of time.
A bibliography can be found in annex 3.
17
.................................................................................. ..................................................................................
Although many WHO regions have experienced increases 
in their pharmacist workforce (notably the Eastern 
Mediterranean and Africa) over the period 2006–12, countries 
that are classified by the World Bank as low or lower middle 
income still have a very low density of pharmacists compared 
with those nations classified as high or upper middle income. 
It has been well documented that for low income countries 
in particular there is a shortage of healthcare professionals 
needed to deal with the local disease burden. Such countries’ 
increases in workforce (where they can be achieved) might not 
be keeping pace with the increases in population and shifts in 
disease burden.  
It is essential to monitor the global pharmacist workforce 
trends at regular time points so that decisions can be made as 
to how countries can deploy their workforce. There is also an 
increasing international transfer of healthcare professionals. 
The WHO is rightly pushing for health equity as a global 
human right and having access to a pharmacist is key to 
that since medicines represent one of the most important 
interventions in health.
PART 5   
SUMMARY AND CONCLUSIONS
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Country
Argentina
Australia
Austria
Belgium
Brazil
Cameroon
Canada
Costa Rica
Croatia
Czech Republic
Egypt
Ethiopia
Finland
France
Germany
Ghana
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Jordan
Kenya
Population
 38,747,000 
 20,394,800 
 8,151,000 
 10,480,000 
 184,184,000 
 18,137,734 
 32,225,000 
 4,320,130 
 4,442,000 
 10,212,000 
 71,777,678 
 76,167,240 
 5,246,096 
 60,742,000 
 82,490,000 
 22,019,000 
 10,086,000 
 295,000 
 1,103,596,000 
 221,932,000 
 4,125,000 
 7,105,000 
 58,742,000 
 127,728,000 
 5,411,000 
 33,830,000 
Data 2006
Pharmacist
density**
5.04
7.52
5.82
11.60
4.92
0.39
8.86
no data
5.18
5.85
12.89
0.02
7.24
11.61
6.53
0.74
7.71
12.54
5.24
0.68
8.50
4.22
7.98
17.99
12.42
0.39
Population
 39,746,000 
 21,249,200 
 8,352,000 
 10,695,000 
 195,138,000 
 19,595,026 
 33,304,000 
 4,519,000 
 4,433,000 
 10,428,000 
 75,491,922 
 79,087,000 
 5,313,399 
 62,046,000 
 82,110,097 
 23,947,000 
 10,034,000 
 319,000 
 1,149,285,000 
 239,945,000 
 4,535,000 
 7,482,000 
 59,865,000 
 127,720,000 
 5,849,000 
 37,954,000 
Data 2009 Data 2012
Pharmacist 
density**
5.15
8.87
6.37
11.69
6.39
0.36
9.31
6.24
6.73
7.14
17.63
0.14
5.49
11.69
9.14
0.75
6.48
12.63
5.71
0.71
9.81
6.68
10.94
19.77
14.38
0.42
Population
 40,728,738 
 22,340,000 
 8,406,187 
 11,047,744 
 196,900,000 
 21,156,272 
 34,468,000 
 4,726,600 
 4,280,622 
 10,546,000 
 82,637,400 
 87,118,000 
 5,388,272 
 63,305,000 
 81,797,673 
 24,965,800 
 9,972,000 
 318,900 
 1,241,275,000 
 243,801,639 
 4,584,000 
 7,856,000 
 60,769,000 
 128,100,000 
 6,632,000 
 41,609,700 
Pharmacist
density**
no data
11.64
6.93
11.63
9.10
0.40
10.17
8.00
7.17
7.62
18.15
0.22
5.80
11.57
9.58
1.19
5.70
13.64
5.29
1.05
10.46
7.38
13.47
21.59
20.87
0.53
WBC*
3
4
4
4
2
2
4
3
4
4
2
1
4
4
4
2
4
4
2
2
4
4
4
4
3
1
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Notes:
* WBC – World Bank Classification. The World Bank classifies countries incomes as:  high (4) upper middle (3); lower middle (2) and low (1).
** Density as pharmacists per 10,000 population.
Country
Korea, Rep of
Mali
Malta
Mexico
Nepal
Nigeria
Norway
Pakistan 
Portugal
Macedonia, Rep of
Singapore
Spain
Sudan
Switzerland
Syria
Taiwan China
Tanzania
Thailand
Turkey
Uganda
United Kingdom
Uruguay
USA
Vietnam
Zimbabwe
Population
 48,138,077 
 11,941,258.0  
 403,834 
 112,100,000 
 25,292,058 
 143,300,000 
 4,620,000 
 157,971,415 
 10,576,000 
 2,090,044 
 4,296,000 
 44,710,000 
 31,585,871 
 7,446,000 
 18,167,367 
 22,731,000 
 38,824,384 
 65,002,000 
 72,907,000 
 28,724,869 
 60,068,000 
 3,419,000 
 296,483,000 
 82,392,100 
 12,710,589 
Data 2006
Pharmacist
density**
11.60
no data
20.73
no data
no data
0.87
4.34
0.51
8.74
no data
2.88
9.20
0.48
7.21
7.00
13.04
no data
2.91
3.31
0.06
7.83
3.22
7.66
no data
no data
Population
 48,607,000 
 12,716,000 
 409,379 
 107,677,000 
 26,997,000 
 148,071,000 
 4,661,000 
 172,800,000 
 10,621,000 
 2,049,000 
 4,790,000 
 46,501,000 
 39,445,000 
 7,633,000 
 19,933,000 
22 770 383
 40,213,000 
 66,185,340 
 74,766,000 
 29,194,000 
 61,291,000 
 3,334,000 
 304,486,000 
 85,122,300 
 13,481,000 
Data 2009 Data 2012
Pharmacist 
density**
11.76
0.64
20.01
5.39
0.20
0.89
4.71
0.69
10.46
7.38
3.10
13.18
1.49
8.23
7.47
no data
0.17
no data
4.11
0.10
7.99
3.63
9.06
1.20
0.80
Population
 49,779,440 
 15,394,000 
 416,268 
 114,793,300 
 30,486,000 
 162,265,000 
 4,952,000 
 176,940,000 
 10,653,000 
 2,059,000 
 5,167,000 
 46,742,697 
 36,430,923 
 7,868,000 
 21,961,676 
 23,176,000 
 46,218,500 
 69,519,000 
 73,950,000 
 34,543,300 
 62,736,000 
 3,383,486 
 311,695,000 
 87,840,000 
 12,084,000 
Pharmacist
density**
6.54
0.69
24.82
5.23
0.39
0.95
5.25
0.68
12.56
9.94
3.90
13.74
no data
8.45
no data
17.26
0.20
4.07
4.33
0.16
8.08
no data
8.82
1.37
0.56
WBC*
4
1
4
3
1
1
4
2
4
3
4
4
1
4
2
3
1
3
3
1
4
4
4
2
1
Annex 1. Data Table
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Annex 2. ISO 3-Digit Table 
Country 
Argentina 
Australia 
Austria 
Belgium 
Brazil 
Cameroon
Canada 
Costa Rica
Croatia 
Czech Republic 
Egypt, Arab Rep. 
Ethiopia 
Finland 
France 
Germany 
Ghana 
Hungary 
Iceland 
India 
Indonesia 
Ireland
Israel 
Italy 
Japan
Jordan
Kenya  
ISO 3-digit 
Country Code
ARG
AUS
AUT
BEL 
BRA
CMR
CAN
 CRI
HRV
CZE
EGY 
ETH
FIN
FRA
DEU
GHA
HUN
ISL
IND 
IDN
IRL
ISR 
ITA 
JPN
JOR 
KEN
Country 
 
Korea, Rep.
Macedonia, Rep 
Mali
Malta 
Mexico
Nepal 
Nigeria 
Norway 
Pakistan 
Portugal 
Singapore 
Spain
Sudan
Switzerland 
Syria
Taiwan, China 
Tanzania 
Thailand 
Turkey 
Uganda 
United Kingdom 
United States
Uruguay 
Vietnam 
Zimbabwe 
ISO 3-digit 
Country Code
KOR
MKD
MLI 
MLT
MEX
NPL 
NGA
NOR 
PAK 
PRT
SGP 
ESP
 SUD  
CHE 
SYR
TWN
TZA
THA
TUR 
UGA 
GBR
USA
URY
VNM
ZWE  
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